Live
Home·Deals·Pharmaceuticals·AstraZeneca acquires CSPC Pharmaceutical Group
AstraZeneca acquires CSPC Pharmaceutical Group (2026)
SEO URLwww.firestrike.ai/deals/cspc-pharmaceutical-group-astrazeneca-acquisition-2026
acquisitionAnnounced · Jan 30, 2026PharmaceuticalsSource · Unverified ReportsArticle · Factual
CSPC Pharmaceutical Group
AstraZeneca
CSPC Pharmaceutical Group · AstraZeneca

AstraZeneca acquires CSPC Pharmaceutical Group

David Najork
David Najork · Founding Software Engineer
Announced · Updated · 1 min read
ShareXLinkedInEmail
Deal value
$5B
Target
CSPC Pharmaceutical Group
CSPC Pharmaceutical Group
Acquirer
AstraZeneca
AstraZeneca
Financial Stake
Status
Announced

AstraZeneca agreed to acquire CSPC Pharmaceutical Group. Reported deal value: $5B. Status: Announced. Sector: Pharmaceuticals. Target headquarters context: Location not specified.

This page summarizes publicly available information about the transaction as of 2026-01-30. Figures and status may change as filings and press coverage update.

Having outlined an £11 billion investment programme in China on Thursday, AstraZeneca yesterday announced a tie-up with CSPC Pharmaceutical Group to ramp up development of weight - loss and diabetes drug s

Deal timeline

Announced
Jan 30, 2026 · dailymail.co.uk
Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.
Sector context

This transaction is classified in Pharmaceuticals with a reported deal value of $5B. Figures and status may change as sources update.

Sources: dailymail.co.uk · Primary article · FireStrike proprietary index